Guidelines for reporting outcomes in trial reports: the CONSORT-outcomes 2022 extension

NJ Butcher, A Monsour, EJ Mew, AW Chan, D Moher… - Jama, 2022 - jamanetwork.com
Importance Clinicians, patients, and policy makers rely on published results from clinical
trials to help make evidence-informed decisions. To critically evaluate and use trial results …

[HTML][HTML] Diagnostic accuracy of deep learning in medical imaging: a systematic review and meta-analysis

R Aggarwal, V Sounderajah, G Martin, DSW Ting… - NPJ digital …, 2021 - nature.com
Deep learning (DL) has the potential to transform medical diagnostics. However, the
diagnostic accuracy of DL is uncertain. Our aim was to evaluate the diagnostic accuracy of …

[HTML][HTML] MRI-targeted or standard biopsy in prostate cancer screening

M Eklund, F Jäderling, A Discacciati… - New England journal …, 2021 - Mass Medical Soc
Background High rates of overdiagnosis are a critical barrier to organized prostate cancer
screening. Magnetic resonance imaging (MRI) with targeted biopsy has shown the potential …

Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement

MJ Page, JE McKenzie, PM Bossuyt, I Boutron… - Journal of clinical …, 2021 - Elsevier
Objectives To describe the processes used to update the PRISMA 2009 statement for
reporting systematic reviews, present results of a survey conducted to inform the update …

[HTML][HTML] Effect of early treatment with ivermectin among patients with Covid-19

G Reis, EASM Silva, DCM Silva… - … England Journal of …, 2022 - Mass Medical Soc
Background The efficacy of ivermectin in preventing hospitalization or extended observation
in an emergency setting among outpatients with acutely symptomatic coronavirus disease …

Guidelines for reporting trial protocols and completed trials modified due to the COVID-19 pandemic and other extenuating circumstances: the CONSERVE 2021 …

AM Orkin, PJ Gill, D Ghersi, L Campbell, J Sugarman… - Jama, 2021 - jamanetwork.com
Importance Extenuating circumstances can trigger unplanned changes to randomized trials
and introduce methodological, ethical, feasibility, and analytical challenges that can …

Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for …

ME Castillo, LME Costa, JMV Barrios, JFA Díaz… - The Journal of steroid …, 2020 - Elsevier
Objective The vitamin D endocrine system may have a variety of actions on cells and tissues
involved in COVID-19 progression especially by decreasing the Acute Respiratory Distress …

Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial

C Salvarani, G Dolci, M Massari, DF Merlo… - JAMA internal …, 2021 - jamanetwork.com
Importance The coronavirus disease 2019 (COVID-19) pandemic is threatening billions of
people worldwide. Tocilizumab has shown promising results in retrospective studies in …

Ivermectin for preventing and treating COVID‐19

M Popp, M Stegemann, MI Metzendorf… - Cochrane Database …, 2021 - cochranelibrary.com
Background Ivermectin, an antiparasitic agent used to treat parasitic infestations, inhibits the
replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of …

Checklist for artificial intelligence in medical imaging (CLAIM): a guide for authors and reviewers

J Mongan, L Moy, CE Kahn Jr - Radiology: Artificial Intelligence, 2020 - pubs.rsna.org
Study Design Item 5. Indicate if the study is retrospective or prospective. Evaluate predictive
models in a prospective setting, if possible. Item 6. Define the study's goal, such as model …